These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34486922)

  • 21. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.
    Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW
    Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
    Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.
    Lombardi Fäh V; Catarino R; Castillo S; Badda M; Gezer-Dickschat S; Thieringer F; Tschudin S; Viviano M; Yaron M
    BMC Res Notes; 2023 Mar; 16(1):35. PubMed ID: 36915205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
    Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
    Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Etonogestrel-Releasing Contraceptive Implant with Reduced Weight Gain in an Exclusively Breastfed Infant: Report and Literature Review.
    Stuebe AM; Bryant AG; Lewis R; Muddana A
    Breastfeed Med; 2016 May; 11(4):203-6. PubMed ID: 27032034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
    Vetrichevvel TP; Pise GA; Thappa DM
    Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short report: erythema nodosum leprosum lymphadenitis.
    Fiallo P; Pesce C; Lenti E; Nunzi E
    Am J Trop Med Hyg; 1995 Apr; 52(4):297-8. PubMed ID: 7741163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Traumatic Incomplete Fracture of an Implanon NXT® Contraceptive Implant.
    Howett R; Gertz AM; Kgaswanyane T; Petro G; Morroni C
    Afr J Reprod Health; 2019 Dec; 23(4):124-128. PubMed ID: 32227747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
    López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
    J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
    Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
    Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.
    Brito MB; Ferriani RA; Meijers JC; Garcia AA; Quintana SM; Silva de Sá MF; Vieira CS
    Thromb Res; 2012 Sep; 130(3):355-60. PubMed ID: 22542366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
    Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
    Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.